MOREPEN LABORATORIES Financial Statement Analysis
|
||
The Revenues of MOREPEN LABORATORIES have increased by 30.20% YoY .
The Earnings Per Share (EPS) of MOREPEN LABORATORIES has decreased by -64.32 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
MOREPEN LABORATORIES Last 5 Annual Financial Results
[BOM: 500288|NSE : MOREPENLAB]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹1,547 Cr | ₹1,188 Cr | ₹853 Cr | ₹769 Cr | ₹607 Cr |
Expenses | ₹1,410 Cr | ₹1,070 Cr | ₹785 Cr | ₹701 Cr | ₹542 Cr |
Operating Profit (Excl OI) | ₹137 Cr | ₹119 Cr | ₹69 Cr | ₹68 Cr | ₹65 Cr |
Other Income | ₹20 Cr | ₹12 Cr | ₹9.48 Cr | ₹3.67 Cr | ₹3.72 Cr |
Interest | ₹2.43 Cr | ₹1.79 Cr | ₹1.99 Cr | ₹2.11 Cr | ₹4.36 Cr |
Depreciation | ₹28 Cr | ₹30 Cr | ₹37 Cr | ₹40 Cr | ₹34 Cr |
Profit Before Tax | ₹127 Cr | ₹99 Cr | ₹39 Cr | ₹29 Cr | ₹30 Cr |
Profit After Tax | ₹102 Cr | ₹97 Cr | ₹34 Cr | ₹29 Cr | ₹30 Cr |
Consolidated Net Profit | ₹102 Cr | ₹97 Cr | ₹34 Cr | ₹29 Cr | ₹30 Cr |
Earnings Per Share (Rs) | ₹0.76 | ₹2.13 | ₹2.16 | ₹0.75 | ₹0.64 |
PAT Margin (%) | 2.73 | 6.57 | 8.17 | 3.94 | 3.75 |
ROE(%) | 5.93 | 21.79 | 29.20 | 12.50 | 12.04 |
ROCE(%) | 8.40 | 24.86 | 27.13 | 12.05 | 10.01 |
Total Debt/Equity(x) | 0.03 | 0.03 | 0.04 | 0.05 | 0.52 |
Key Financials |
||
Market Cap | : | ₹ 2,380.7 Cr |
Revenue (TTM) | : | ₹ 1,631.0 Cr |
Net Profit(TTM) | : | ₹ 76.1 Cr |
EPS (TTM) | : | ₹ 1.5 |
P/E (TTM) | : | 31.3 |
Industry Peers & Returns | 1W | 1M | 1Y |
MOREPEN LABORATORIES | 2.4% | -21.3% | 72.3% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
MOREPEN LABORATORIES Revenues
[BOM: 500288|NSE : MOREPENLAB]
Y-o-Y | 30.20 % |
5 Yr CAGR | 26.37 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹1,547 Cr | 30.20 | |
Mar2022 | ₹1,188 Cr | 39.27 | |
Mar2021 | ₹853 Cr | 11.00 | |
Mar2020 | ₹769 Cr | 26.72 | |
Mar2019 | ₹607 Cr | - |
MOREPEN LABORATORIES Operating Profit
[BOM: 500288|NSE : MOREPENLAB]
Y-o-Y | 15.32 % |
5 Yr CAGR | 20.54 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹137 Cr | 15.32 | |
Mar2022 | ₹119 Cr | 72.98 | |
Mar2021 | ₹69 Cr | 1.48 | |
Mar2020 | ₹68 Cr | 4.31 | |
Mar2019 | ₹65 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -11.42 % |
5 Yr CAGR | -4.59 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 8.84% | -11.42 | |
Mar2022 | 9.98% | 24.28 | |
Mar2021 | 8.03% | -8.65 | |
Mar2020 | 8.79% | -17.62 | |
Mar2019 | 10.67% | - |
MOREPEN LABORATORIES Profit After Tax
[BOM: 500288|NSE : MOREPENLAB]
Y-o-Y | 4.73 % |
5 Yr CAGR | 36.15 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹102 Cr | 4.73 | |
Mar2022 | ₹97 Cr | 189.13 | |
Mar2021 | ₹34 Cr | 16.40 | |
Mar2020 | ₹29 Cr | -2.51 | |
Mar2019 | ₹30 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -58.45 % |
5 Yr CAGR | -7.63 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 2.73 % | -58.45 | |
Mar2022 | 6.57 % | -19.58 | |
Mar2021 | 8.17 % | 107.36 | |
Mar2020 | 3.94 % | 5.07 | |
Mar2019 | 3.75 % | - |
MOREPEN LABORATORIES Earnings Per Share (EPS)
[BOM: 500288|NSE : MOREPENLAB]
Y-o-Y | -64.32 % |
5 Yr CAGR | 4.39 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹0.76 | -64.32 | |
Mar2022 | ₹2.13 | -1.39 | |
Mar2021 | ₹2.16 | 188.00 | |
Mar2020 | ₹0.75 | 17.19 | |
Mar2019 | ₹0.64 | - |
MOREPEN LABORATORIES Return on Capital Employed (ROCE)
[BOM: 500288|NSE : MOREPENLAB]
Y-o-Y | -66.21 % |
5 Yr CAGR | -4.29 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 8.4% | -66.21 | |
Mar2022 | 24.86% | -8.37 | |
Mar2021 | 27.13% | 125.15 | |
Mar2020 | 12.05% | 20.38 | |
Mar2019 | 10.01% | - |
MOREPEN LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹46.6 |
Current MarketCap | : | ₹ 2,380.7 Cr |
Updated EOD on | : | Apr 18,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MOREPEN LABORATORIES | 2.4% |
-21.3% |
72.3% |
SENSEX | -2.9% |
-0.4% |
20% |
MOREPEN LABORATORIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | -1.1% | 11.8% | 62% |
S&P BSE MIDSMALLCAP | -1.2% | 9.4% | 62.3% |
S&P BSE ALLCAP | -2.2% | 3.9% | 37% |
S&P BSE HEALTHCARE | -3.1% | 2.5% | 51.1% |
You may also like the below Video Courses
FAQ about MOREPEN LABORATORIES Financials
How the annual revenues of MOREPEN LABORATORIES have changed ?
The Revenues of MOREPEN LABORATORIES have increased by 30.20% YoY .
How the Earnings per Share (EPS) of MOREPEN LABORATORIES have changed?
The Earnings Per Share (EPS) of MOREPEN LABORATORIES has decreased by -64.32 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs